Related Articles
Detection of the Epstein-Barr virus in blood and bone marrow mononuclear cells of patients with aggressive B-cell non‑Hodgkin's lymphoma is not associated with prognosis
Clinical characteristics and association analysis of persistent low‑level HBsAg expression in a physical examination population with HBV infection
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Reassessment of the prognostic value of the International Prognostic Index and the revised International Prognostic Index in patients with diffuse large B-cell lymphoma: A multicentre study
Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma